Summary of HR 4030: Treatment Continuity Act of 2025

Purpose and Intent

The Treatment Continuity Act of 2025 aims to enhance the continuity of care for patients undergoing treatment for chronic conditions. The bill seeks to ensure that patients have uninterrupted access to necessary medical services and medications, particularly during transitions between different healthcare providers or systems.

Key Provisions

The bill includes several significant provisions designed to improve treatment continuity:

• Patient Care Coordination: Establishes requirements for healthcare providers to coordinate care for patients transitioning between different treatment settings, such as hospitals, outpatient facilities, and home care.

• Medication Management: Mandates that healthcare providers develop and implement medication management plans to prevent interruptions in prescribed therapies, ensuring patients receive their medications without delay.

• Data Sharing: Encourages the use of interoperable health information technology systems to facilitate the sharing of patient health records among providers, thereby improving communication and reducing the risk of treatment gaps.

• Patient Education: Requires healthcare providers to offer educational resources to patients about their treatment plans and the importance of continuity in care, empowering patients to take an active role in their health management.

Who Would Be Affected

The Treatment Continuity Act of 2025 would primarily impact:

• Patients with Chronic Conditions: Individuals requiring ongoing treatment for conditions such as diabetes, heart disease, and mental health disorders would benefit from improved care coordination and medication management.

• Healthcare Providers: Hospitals, outpatient clinics, and primary care physicians would need to adapt their practices to comply with the new coordination and data-sharing requirements.

• Health Insurance Companies: Insurers may need to adjust their policies and reimbursement models to support the enhanced care continuity measures outlined in the bill.

Procedural Aspects

• Introduced Date: The bill was introduced in the House on June 17, 2025.
• Committee Referral: Following its introduction, HR 4030 was referred to the House Committee on Energy and Commerce for further consideration.

Conclusion

The Treatment Continuity Act of 2025 represents a significant step towards improving the quality of care for patients with chronic conditions by promoting better coordination among healthcare providers and ensuring that patients have consistent access to their treatments. As the bill progresses through the legislative process, its implications for healthcare delivery and patient outcomes will be closely monitored.